A drug to treat acute respiratory distress syndrome (ARDS) is being developed. The drug, Aviptadil, aims to treat ARDS caused by coronavirus disease (COVID-19). Treating ARDS is essential because it is the primary cause of death and morbidity¬†in COVID infection. U.S. pharmaceutical company NeuroRx, Inc. and Relief Therapeutics SA, a Swiss biotechnology company¬†that focuses on […]